These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12727821)

  • 1. Chronic lymphocytic leukemia with prostate infiltration mediated by specific clonal membrane-bound IgM.
    Bogdan CA; Alexander AA; Gorny MK; Matute R; Marjanovic N; Zolla-Pazner S; Walden PD; Furneaux HM; Sidhu GS; Jacobson DR
    Cancer Res; 2003 May; 63(9):2067-71. PubMed ID: 12727821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
    Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
    J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells.
    McConkey DJ; Aguilar-Santelises M; Hartzell P; Eriksson I; Mellstedt H; Orrenius S; Jondal M
    J Immunol; 1991 Feb; 146(3):1072-6. PubMed ID: 1988495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
    Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
    Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood.
    Braylan RC; Jaffe ES; Burbach JW; Frank MM; Johnson RE; Berard CW
    Cancer Res; 1976 May; 36(5):1619-25. PubMed ID: 773529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Binding of natural IgM autoantibodies DJ to T-lymphocytes and T-cell hybridomas and its possible role in apoptosis].
    Zivancević-Simonović S; Inić-Kanada A; Kosec D; Dimitrijević L
    Med Pregl; 2003; 56 Suppl 1():65-71. PubMed ID: 15510917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
    Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
    Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
    Qian GX; Fu SM; Solanki DL; Rai KR
    J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
    Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
    Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells.
    Täger M; Kröning H; Thiel U; Ansorge S
    Exp Hematol; 1997 Jul; 25(7):601-7. PubMed ID: 9216735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
    Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
    Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking of membrane IgM on B CLL cells.
    Grillot-Courvalin C; Hivroz C; Brouet JC
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):301-4. PubMed ID: 3146745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
    Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
    Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.